Transformable Renal Cancer Targeted Responsive Nanopeptide Probes Effectively Inhibit Renal Cancer Progression and Metastasis by Inhibiting Renal Blood Vessels and Cancer Cells
Lists
Only you see this
Abstract
Renal cancer is a highly vascularized tumor, and tumor vasculature accelerates the progression and metastasis of renal cancer. Vascular endothelial growth factor (VEGF) and TIE-2 are the two most essential factors that facilitate tumor angiogenesis; additionally, VEGF has an angiogenesis-independent function in cancer cells that enhances their malignant progression. The long-term inhibition of dual targets, blood vessels and tumor cells, can effectively prevent the progression and metastasis of renal cancer. This study developed a transformable kidney cancer targeting responsive nanopeptide probe (RTP) for the construction of nanofibers in renal cell carcinoma (RCC), which helped to significantly inhibit tumor neovascularization and progression through dual targets. The results showed that RTP reduced angiogenesis to 35.26% ± 4.78% by inhibiting VEGF and TIE-2 and increased tumor cell apoptosis by 6-fold. In vivo validation experiments showed that RTP significantly inhibited tumor angiogenesis and progression. The innovative RTP significantly inhibits renal cancer angiogenesis and may provide a new way to inhibit renal cancer blood vessels and cancer cells.
BibTeX
@inproceedings{kong2025transformable,
author = {Bin Kong and Xiu‐Hai Wu and Cong Li and Pan Liu and Meng Chen and Yuwen Liu and C. Liu and Xinyue Wang and Bogong Chen and Jiahui Zang and Lingrui Jian and Jiachen Shen and Jiaao Yu and Qiang Wu and Guang Yang and Ziqi Wang and Ming Liu and Lu Wang},
title = {{Transformable Renal Cancer Targeted Responsive Nanopeptide Probes Effectively Inhibit Renal Cancer Progression and Metastasis by Inhibiting Renal Blood Vessels and Cancer Cells}},
booktitle = {ACS},
year = {2025},
doi = {10.1021/acsami.5c16546},
}Loading related content...